Roche Holdings AG Basel/ US7711951043 /

12/4/2023 8:49:19 PM	Chg. +0.9800	Volume	Bid-	Ask-	High	Low
35.3400USD	+2.85%	2.96 mill. Turnover: 76.78 mill.	-Bid Size: -	-Ask Size: -	35.4200	34.9900

TeleTrader 3/13/2020 Roche surges 13% on Trump remarks

TeleTrader 7/25/2019 Roche's H1 profit surges 18.5% to 8.9B Swiss francs

GlobeNewswire 5/16/2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic ...

GlobeNewswire 5/16/2019 Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions i...

GlobeNewswire 5/14/2019 New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting ant...

GlobeNewswire 5/14/2019 Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Rep...

GlobeNewswire 5/10/2019 Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Societ...

GlobeNewswire 5/8/2019 Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability...

GlobeNewswire 5/7/2019 Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrop...

GlobeNewswire 5/6/2019 FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer...

GlobeNewswire 4/29/2019 New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio

GlobeNewswire 4/26/2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...

GlobeNewswire 4/23/2019 Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer pat...

GlobeNewswire 4/17/2019 Roche reports a strong start in 2019 and raises the outlook for the full-year

GlobeNewswire 4/3/2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...

GlobeNewswire 4/1/2019 Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activ...

GlobeNewswire 3/19/2019 FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults ...

GlobeNewswire 3/15/2019 European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease

GlobeNewswire 3/14/2019 European Commission approves Roche's Hemlibra for people with severe haemophilia A without factor VI...

GlobeNewswire 3/11/2019 Roche's VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negati...

GlobeNewswire 3/11/2019 FDA grants Roche's Tecentriq in combination with Abraxane accelerated approval for people with PD-L1...

GlobeNewswire 3/8/2019 European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the ...

GlobeNewswire 3/7/2019 Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in ...

GlobeNewswire 3/7/2019 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untr...

GlobeNewswire 3/5/2019 Roche Annual General Meeting 2019